Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 3:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2761–2784 of 3,983 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Alzheimer Disease, Dementia, Mild, Mild Cognitive Impairment
Interventions: Electroencephalogram (EEG) system, Standard Neuropsychological Testing, Additional neuropsychological tests; Device · Behavioral
Lead sponsor: Boston University; Other
Eligibility: 20 Years to 90 Years
Enrollment: 148 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Preeclampsia, Gestational Diabetes Mellitus (GDM), Preeclampsia (PE), Preeclampsia (PE) Risk, Gestational Diabetes, Gestational Diabetes Mellitus in Pregnancy, Cardiometabolic Diseases, Insulin Resistance, Placental Dysfunction, Pregnancy, Pregnancy Complications, Gestational Complications
Interventions: Not listed
Lead sponsor: University of Tennessee Graduate School of Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Endothelial Dysfunction
Interventions: Not listed
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stroke With Hemiparesis
Interventions: Botulinum Toxin commonly known as BOTOX®, Placebo; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: BRAF Gene Mutation, Hepatic Complication, Renal Failure, Solid Neoplasm
Interventions: Dabrafenib, Laboratory Biomarker Analysis, Pharmacogenomic Study, Pharmacological Study; Drug · Other
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 17
States / cities: Duarte, California • Los Angeles, California • Sacramento, California + 14 more

Conditions: HIV, Endothelial Dysfunction, Inflammation, Insulin Resistance
Interventions: Salsalate; Drug
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Indeterminate Colitis, Functional Abdominal Pain Syndrome, Functional Bowel Disorder, Esophageal Diseases, Gastroduodenal Disorder, Bowel Dysfunction, Gallbladder Diseases, Sphincter of Oddi Dysfunction, Anorectal Disorder
Interventions: Esophagogastroduodenoscopy (EGD) with biopsy, Colonoscopy w/ biopsy; Diagnostic Test
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 6 Years to 21 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Urinary Retention, Neurogenic Bladder, Urologic Diseases
Interventions: Connected Urinary Catheter; Device
Lead sponsor: Spinal Singularity; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 9
States / cities: Downey, California • Inglewood, California • Murrieta, California + 6 more

Conditions: Dry Eye Disease
Interventions: Propylene glycol-based eye drops; Other
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Kansas City, Missouri • Norfolk, Virginia

Conditions: Mild Cognitive Impairment
Interventions: Growth Hormone Releasing Hormone (GHRH), Placebo Growth Hormone Releasing Hormone; Drug
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 55 Years to 85 Years
Enrollment: 22 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Inflammation, Cognitive Impairment, Anxiety, Alcohol Drinking
Interventions: Physical Activity, Usual Care; Behavioral · Other
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 65 Years to 84 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Chronic Fatigue Syndrome
Interventions: Not listed
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Bladder Pain Syndrome, Female Sexual Dysfunction
Interventions: Onabotulinum toxin A, Conservative management (dietary and behavioral); Drug · Behavioral
Lead sponsor: Walter Reed National Military Medical Center; Federal
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 159 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Somatosensory Disorders
Interventions: Vibration Plate Therapy; Device
Lead sponsor: Logan College of Chiropractic; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Chesterfield, Missouri

Conditions: Older Adults, Multiple Sclerosis, Cognitive Impairment, Walking Impairment
Interventions: Aerobic and Resistance Exercise Program (GEMS program), Flexibility and Stretching Program (FLEX-MS program); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 50 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: HIV, Vascular Diseases, Cardiovascular Diseases, Atherosclerosis, HIV Infections
Interventions: Combination antiretroviral therapy (cART), Pentoxifylline, Placebo; Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cancer, Cognitive Impairment
Interventions: Behavioral: COPE +; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 100 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)
Interventions: Finerenone (Kerendia, BAY94-8862); Drug
Lead sponsor: Bayer; Industry
Eligibility: Up to 18 Years
Enrollment: 117 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 22
States / cities: Aurora, Colorado • Wilmington, Delaware • Gainesville, Florida + 18 more

Conditions: Healthy Volunteer, Sjogren's Syndrome, Salivary Gland Disease
Interventions: Not listed
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 4 Years to 100 Years
Enrollment: 1,150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2032
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Paget's Disease of Bone
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Fibromyalgia, Exercise, Pain, Autonomic Dysfunction, Physical Activity
Interventions: Exercise, Cognitive Task; Other
Lead sponsor: Marquette University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Mild Cognitive Impairment, Subjective Cognitive Decline (SCD)
Interventions: Virtual Reality (VR) sessions; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 55 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Exercise-induced Inflammation, Exercise-induced Oxidative Stress, Exercise-induced Immune Dysfunction
Interventions: Nutrasorb, Placebo; Dietary Supplement
Lead sponsor: Appalachian State University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Kannapolis, North Carolina

Conditions: Ventilator Induced Diaphragm Dysfunction
Interventions: Lungpacer DPTS (Diaphragm Pacing Therapy System); Device
Lead sponsor: Lungpacer Medical Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 4
States / cities: Gainesville, Florida • New York, New York • Philadelphia, Pennsylvania + 1 more

Search by objective public record fields.

Event-Related Potential (ERP) Components in Clinical Diagnosis

Cardiometabolic Disease and Substrate Metabolism

Endothelial Dysfunction As A Predictor Of Perioperative Outcome

Study of Botulinum Toxin and Recovery of Hand Function After Stroke

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Safety and Efficacy of Salsalate to Treat Endothelial Dysfunction in HIV-infected Adults

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Connected Catheter- Safety and Effectiveness Study

Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease

The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

Trial Assessing Light Intensity Exercise on the Health of Older Breast Cancer Survivors

ME/CFS: Activity Patterns and Autonomic Dysfunction

Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome

Application of Specific Frequencies to Stimulate the Spinocerebellar Tract in Subjects With Unilateral Dysafferentation

Exercise Training, Cognition, and Mobility in Older Adults With Multiple Sclerosis

Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People

Cancer and Mild Cognitive Impairment Dyadic Intervention

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Characterization of Diseases With Salivary Gland Involvement

Pathophysiology of Paget's Disease of Bone

Cardiovascular Autonomic Function and Endogenous Pain Modulation

Feasibility, Usability, and Acceptability of Virtual Reality-Based Cognitive and Physical Rehabilitation in Individuals With Mild Cognitive Impairment

Polyphenols, Exercise, and Metabolomics

Percutaneous Temporary Placement of a Phrenic Nerve Stimulator for Diaphragm Pacing (RESCUE1)